Clinical Trial Update: Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports on conditioning with benadamustine, fludarabine, and busulfan (FluBuBe) for recipients of haploidentical stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Lymphoblastic Lymphoma
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• BUSULFAN (Busulfan)
• Benadamustine (benadamustine)
• Fludarabine (Fludarabine)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute | Phase 2 | Status: COMPLETED